Tuberculosis: Immunology, Cell Biology and Novel Vaccination Strategies is the most considerable event that will present all-encompassing knowledge regarding Tuberculosis (TB). The summit will discuss the latest results on clinical trials of drug and vaccine candidates. The conference will spotlight research on host-pathogen crosstalk at the basic cellular and molecular level along with human studies that determine the start of susceptibility to and severity of tuberculosis. Tuberculosis: Immunology, Cell Biology and Novel Vaccination Strategies will highlight various topics on the molecular genetics and biochemistry of the pathogen with emphasis on unique lineage and growth state-specific features and the immunology and molecular genetics of the host during latency, reactivation and active disease. The meeting will bestow information on new-fangled measures for Tuberculosis control including pre- and post-exposure vaccination strategies, combat of extensively drug-resistant strains, and novel therapeutic stratagems to avoid IRIS.
The targeted visitors at Tuberculosis: Immunology, Cell Biology and Novel Vaccination Strategies are:
- Clinical Nurse Practitioner
- Medical Professionals
- Pharmaceutical Companies
Keystone Symposia on Molecular and Cellular Biology